Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine

Florian Krammer, Komal Srivastava, Hala Alshammary, Angela A. Amoako, Mahmoud Awawda, Katherine F. Beach, Maria C. Bermúdez‐González, Dominika Bielak, Juan Manuel Carreño, Rachel Chernet, Lily Eaker, Emily D. Ferreri, Daniel Floda, Charles Gleason, Joshua Hamburger, Kaijun Jiang, Giulio Kleiner, Denise Jurczyszak, Julia C. Matthews, Wanni A. Mendez, Ismail Nabeel, Lubbertus C. F. Mulder, Ariel Raskin, Kayla T. Russo, Ashley-Beathrese T. Salimbangon, Miti Saksena, Amber S. Shin, Gagandeep Singh, Levy A. Sominsky, Daniel Stadlbauer, Ania Wajnberg, Viviana Simon

2021New England Journal of Medicine803 citationsDOI Open Access PDF

Abstract

Responses of Seropositive Persons to a Single SARS-CoV-2 Vaccine Some persons who have recovered from Covid-19 have antibodies to the spike protein of SARS-CoV-2. In 43 such persons who had receive...

Topics & Concepts

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)MedicineVirologyAntibodyCoronavirus disease 2019 (COVID-19)Immunology2019-20 coronavirus outbreakAntibody responseSpike ProteinOutbreakInternal medicineInfectious disease (medical specialty)DiseaseSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesVaccine Coverage and Hesitancy